Do current clinical trials meet society's needs?: a critical review of recent evidence

Stuart J Pocock1, Bernard J Gersh2

  • 1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Insights

Current cardiology clinical trials face significant challenges, including issues with medical device research, industry funding, and treatment comparisons. Addressing these controversies is crucial for ensuring trials meet societal expectations and advance patient care effectively.

Area of Science:

  • Clinical Trials Research
  • Cardiology
  • Medical Research Ethics

Background:

  • The current landscape of clinical trials research in cardiology is marked by several critical controversies.
  • These issues impact the reliability, efficiency, and ethical considerations of cardiovascular research.
  • Understanding these controversies is vital for improving the future of clinical trials.

Purpose of the Study:

  • To critically examine and discuss key controversies in contemporary cardiology clinical trials.
  • To evaluate the success of current clinical trial practices in meeting societal expectations.
  • To identify areas for improvement in the design, execution, and reporting of cardiovascular trials.

Main Methods:

  • Review and analysis of current controversies in cardiology clinical trials.
  • Discussion of specific issues including medical device trials, industry sponsorship, and comparative effectiveness.
  • Illustration of points with recent and relevant clinical trials in cardiology.

Main Results:

  • Inadequacies in medical device trial research and issues with industry-sponsored trials are prevalent.
  • A lack of head-to-head trials for effective treatments and concerns regarding drug safety handling are noted.
  • Challenges exist in trial report credibility, globalization, personalized medicine integration, and the need for trials on old drugs and treatment withdrawal.

Conclusions:

  • Current clinical trials in cardiology face numerous challenges that question their ability to meet societal expectations.
  • Improvements are needed in trial design, funding transparency, comparative effectiveness research, and reporting standards.
  • Re-evaluation of trial methodologies, including pragmatic trials and personalized medicine, is essential for advancing cardiovascular care.

Related Concept Videos

Case Studies01:22

Case Studies

There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
Current Trends in Nursing II01:30

Current Trends in Nursing II

Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...